Amgen promotes two senior executives
pharmafile | October 29, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Amgen
Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president.
McNamee (pictured) will continue to report directly to Robert Bradway, Amgen’s chairman and chief executive. He joined Amgen in 2001 and has served as senior vice president of human resources for the past 12 years.
McNamee brings over 25 years of management experience to his new role. Prior to joining the firm he spent 12 years with General Electric. During this tenure he was involved in the launch of multiple transformational programmes, including the deployment of WorkOut, the Change Acceleration Programme.
Bradway said: “Brian has been a tireless advocate in building the talent base at Amgen, even as he has served as a trusted business counsellor to me and our entire senior leadership team.”
Tross will be responsible for Amgen’s global HR activities, succeeding McNamee in this role. He will also report directly to Bradway.
Tross joined Amgen in 2006 and most recently served as vice president of HR for Amgen’s R&D group. Prior to that, he was vice president of HR for the office of the chief operating officer and earlier, served in the same capacity for the global commercial operations unit.
Prior to joining the firm Tross worked at Bristol-Myers Squibb where he served as vice president of global HR for Mead Johnson Nutrition. Earlier in his career, Tross was a management consultant for Towers Perrin (now Towers Watson).
Bradway said: “I am delighted to have Stuart Tross leading human resources for Amgen. His experience and leadership will be critical for Amgen as we create an organisation that is positioned to drive future growth.”
Related Content
FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) …
Amgen opens new biomanufacturing facility in Ohio, US
Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. …
AstraZeneca and Amgen asthma drug shows positive results in Phase III trial
AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority …
